Regulation of Glucagon Secretion in Normal and Diabetic Human Islets by γ-Hydroxybutyrate and Glycine
Year: 2012
Type: article
Abstract: Paracrine signaling between pancreatic islet β-cells and α-cells has been proposed to play a role in regulating glucagon responses to elevated glucose and hypoglycemia. To examine this possibility in human islets, we used a metabolomic approach to trace the responses of amino acids and other potential neurotransmitters to stimulation with [U- 13 C]glucose in both normal individuals and type 2 diabetics. Islets from type 2 diabetics uniformly showed decreased glucose stimulation of insulin secretion and respiratory rate but demonstrated two different patterns of glucagon responses to glucose: one group responded normally to suppression of glucagon by glucose, but the second group was non-responsive. The non-responsive group showed evidence of suppressed islet GABA levels and of GABA shunt activity. In further studies with normal human islets, we found that γ-hydroxybutyrate (GHB), a potent inhibitory neurotransmitter, is generated in β-cells by an extension of the GABA shunt during glucose stimulation and interacts with α-cell GHB receptors, thus mediating the suppressive effect of glucose on glucagon release. We also identified glycine, acting via α-cell glycine receptors, as the predominant amino acid stimulator of glucagon release. The results suggest that glycine and GHB provide a counterbalancing receptor-based mechanism for controlling α-cell secretory responses to metabolic fuels. Background: β-Cells regulate α-cells via paracrine mechanisms. Results: A GABA shunt defect impairs glucose suppression of glucagon secretion in diabetic human islets. Glucagon secretion is inhibited by γ-hydroxybutyrate produced by β-cells but is stimulated by glycine via plasma membrane receptors. Conclusion: γ-Hydroxybutyrate and glycine serve as counterbalancing receptor-based regulators of glucagon secretion. Significance: Amino acids and their metabolites are central regulators of α-cell function.
Source: Journal of Biological Chemistry
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Funders: American Diabetes Association, University of Pennsylvania, National Institutes of Health, Perelman School of Medicine, University of Pennsylvania, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: G1625321772, G1661754476, Intellectual and Development Disabilities Research Center, G2836111075, Regulation of 15N Urea Isotopomers Production, G371062292, Metabolism of islets of langerhans and hormone release, Isolation and Distribution of high quality human pancreatic islets, Epigenomics of the regenerating and aging beta-cell, B-Lymphocyte Immunotherapy in Islet Transplantation, Molecular Basis of a New Form of Hyperinsulinism, Islet Dysregulation in Infants with Congenital Hyperinsulinism, Regulation of 15N Urea Isotopomers Production, G9000282825, University of Pennsylvania Diabetes Research Center
OpenAlex ID: W2026640914
